Proto Labs (PRLB) Misses Q3 EPS by 1c

Proto Labs (NYSE: PRLB) reported Q3 EPS of $0.52, $0.01 worse than the analyst estimate of $0.53. Revenue for the quarter came in at $67.8 million versus the consensus estimate of $67.04 million.

For earnings history and earnings-related data on Proto Labs (PRLB) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Dutch Bros Inc. (BROS) PT Raised to $90 at DA Davidson on Sales/Earnings Upside
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion